About: Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring
Creator	Aleppo, Grazia Beck, Roy Bergenstal, Richard Bugielski, Brian Calhoun, Peter Cohen, Nathan Cushman, Terra Gal, Robin Haban, Amanda Hood, Korey Johnson, Mary Kruger, Davida Olson, Beth Oser, Sean Oser, Tamara Strayer, Heidi Weinstock, Ruth Mcarthur, Teresa
source	PMC
abstract	The purpose of this study was to evaluate feasibility of initiating continuous glucose monitoring (CGM) through telehealth as a means of expanding access. Adults with type 1 diabetes (N = 27) or type 2 diabetes using insulin (N = 7) and interest in starting CGM selected a CGM system (Dexcom G6 or Abbott FreeStyle Libre), which they received by mail. CGM was initiated with a certified diabetes care and education specialist providing instruction via videoconference or phone. The primary outcome was days per week of CGM use during the last 4 weeks. Hemoglobin A(1c) (HbA(1c)) was measured at baseline and 12 weeks. Participant self-reported outcome measures were also evaluated. All 34 participants (mean age, 46 ± 18 years; 53% female, 85% white) were using CGM at 12 weeks, with 94% using CGM at least 6 days per week during weeks 9 to 12. Mean HbA(1c) decreased from 8.3 ± 1.6 at baseline to 7.2 ± 1.3 at 12 weeks (P < .001) and mean time in range (70-180 mg/dL, 3.9-10.0 mmol/L) increased from an estimated 48% ± 18% to 59% ± 20% (P < .001), an increase of approximately 2.7 hours/day. Substantial benefits of CGM to quality of life were observed, with reduced diabetes distress, increased satisfaction with glucose monitoring, and fewer perceived technology barriers to management. Remote CGM initiation was successful in achieving sustained use and improving glycemic control after 12 weeks as well as improving quality-of-life indicators. If widely implemented, this telehealth approach could substantially increase the adoption of CGM and potentially improve glycemic control for people with diabetes using insulin.
has issue date	2020-06-23(xsd:dateTime)
bibo:doi	10.1210/jendso/bvaa076
has license	cc-by-nc-nd
sha1sum (hex)	79b597146d98d6e9d16ea5a3abafa2b6d93506db
schema:url	https://doi.org/10.1210/jendso/bvaa076
resource representing a document's title	Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring
has PubMed Central identifier	PMC7448105
schema:publication	J Endocr Soc
resource representing a document's body	covid:79b597146d98d6e9d16ea5a3abafa2b6d93506db#body_text
is schema:about of	named entity 'Weinstock' named entity 'ORCiD' named entity 'Continuous Glucose Monitoring' named entity 'CGM' named entity 'diabetes' named entity 'primary care' named entity 'diabetes' named entity 'type 2 diabetes' named entity 'T2D' named entity 'diabetes care' named entity 'questionnaire' named entity 'T2D' named entity 'practice-based research network' named entity '12 weeks' named entity 'diabetes management' named entity 'diabetes' named entity 'randomized trials' named entity 'Hypoglycemia' named entity 'people with diabetes' named entity 'Food and Drug Administration' named entity 'CGM' named entity 'sensor' named entity 'Telehealth' named entity 'CGM' named entity 'insulin pump' named entity 'insulin' named entity 'CGM' named entity 'insulin' named entity 'University of Minnesota' named entity 'CGM' named entity 'T1D' named entity 'diabetes' named entity 'T2D' named entity 'T2D' named entity 'CGM' named entity 'Tosoh' named entity 'T2D' named entity 'T1D' named entity 'insulin' named entity 'CGM' named entity 'CGM' named entity 'CGM' named entity 'diabetes' named entity 'self-management' named entity 'glucose' named entity 'clinical care' named entity 'T1D' named entity 'telehealth' named entity 'CGM' named entity 'diabetes' named entity 'insulin' named entity 'glucose monitoring' named entity 'primary care providers' named entity 'American Association of Clinical Endocrinologists' named entity 'hemoglobin' named entity '12 weeks' named entity 'CGM' named entity 'United States' named entity 'informed consent' named entity 'Wisconsin' named entity 'CGM' named entity 'hypoglycemia' named entity 'self-efficacy' named entity '1.6' named entity 'CGM' named entity 'T1D'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software